What's New in Pigmentary Disorders.
Dermatol Clin
; 37(2): 175-181, 2019 Apr.
Article
en En
| MEDLINE
| ID: mdl-30850040
ABSTRACT
Pigmentary disorders are common and can be very distressing to patients. There is a need for better, standardized therapies. The authors review the most recent data for topical, systemic, light, and laser treatments for vitiligo, melasma, and postinflammatory hyperpigmentation. There is a paucity of large-scale, well-designed, randomized, controlled trials for these treatments. Treatment options are often drawn from smaller trials and case series. The treatments described in this article are promising candidates for larger follow-up studies.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Métodos Terapéuticos y Terapias MTCI:
Terapias_energeticas
Asunto principal:
Trastornos de la Pigmentación
/
Fármacos Dermatológicos
/
Inhibidores de las Cinasas Janus
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Idioma:
En
Revista:
Dermatol Clin
Año:
2019
Tipo del documento:
Article
País de afiliación:
Estados Unidos